Sleep-Disordered Breathing and Interactions with Opioids: A Narrative Review

Area of Science:

• Sleep Medicine
• Pain Management
• Pharmacology

Background:

• Opioid use impairs respiratory drive via mu-opioid receptor activation, worsening obstructive and central sleep apneas (SDB).
• Chronic opioid use is associated with central sleep apnea and nocturnal hypoventilation.
• Sleep disordered breathing exacerbates pain sensitivity through intermittent hypoxia, inflammation, and neural plasticity changes, potentially affecting opioid efficacy.

Purpose of the Study:

• To review the complex interactions between sleep disordered breathing and opioid use in chronic pain management.
• To elucidate the underlying mechanisms, clinical impacts, and therapeutic strategies for this patient population.

Main Methods:

• Literature review summarizing current evidence on SDB and opioid interactions.
• Discussion of mechanistic pathways and clinical implications.
• Exploration of diagnostic and therapeutic advancements.

Main Results:

• The interplay between SDB and opioid use presents significant therapeutic challenges.
• SDB can alter opioid efficacy and dosing requirements.
• A bidirectional relationship exists where each condition negatively impacts the other.

Conclusions:

• The intersection of SDB and opioid use requires a multidisciplinary approach for optimal patient care.
• Enhanced screening, personalized pharmacologic strategies, and advanced diagnostics are crucial.
• Further mechanistic studies and interventional trials are needed for evidence-based management.